How Purdue planted its ‘anti-story’ to downplay risks of OxyContin

The Boston Globe Finance 3 weeks ago

Purdue Pharma funded think tanks tapped by the media for expert commentary and facilitated publication of sympathetic articles in leading outlets where its role wasn’t disclosed.


Source link
Read also:
The Boston Globe › Finance › 1 week ago
Purdue’s Richard Sackler proposed plan to play down OxyContin risks, and wanted drug maker feared ‘like a tiger,’ files show.
Raw Story › 3 weeks ago
OxyContin’s makers delayed the reckoning for their role in the opioid crisis by funding think tanks, placing friendly experts on leading outlets, and deterring or challenging negative coverage. In 2004, Purdue Pharma was facing a threat to sales of...
Reuters › Finance › 2 months ago
OxyContin maker Purdue Pharma LP is expected in court on Tuesday to lay out its plan for using bankruptcy to resolve more than 2,600 lawsuits alleging the company fueled the U.S. opioid crisis.
One America News Network › Finance › 3 weeks ago
By Tom Hals (Reuters) - OxyContin maker Purdue Pharma LP got court approval on Tuesday to reimburse millions of dollars in legal fees for states that back its proposed $10 billion settlement of opioid
Reuters › Finance › 3 weeks ago
OxyContin maker Purdue Pharma LP got court approval on Tuesday to reimburse millions of dollars in legal fees for states that back its proposed $10 billion settlement of opioid lawsuits, but with a condition meant to help victims of the addiction...
The New York Times › Finance › 3 weeks ago
OxyContin maker Purdue Pharma LP got court approval on Tuesday to reimburse millions of dollars in legal fees for states that back its proposed $10 billion settlement of opioid lawsuits, but with a condition meant to help victims of the addiction...
Reuters › Finance › 2 months ago
OxyContin maker Purdue Pharma LP filed for bankruptcy protection in New York Sunday night, succumbing to pressure from more than 2,000 lawsuits alleging the company helped fuel the deadly U.S. opioid epidemic.
USA Today › Finance › 2 months ago
OxyContin maker Purdue Pharma filed for bankruptcy protection Sunday, days after reaching a tentative settlement with many state and local governments
The Guardian › 2 months ago
Move comes days after the company reached tentative deal with more than 2,000 plaintiffs Purdue Pharma, the US company that made billions selling the prescription painkiller OxyContin, has filed for bankruptcy, days after reaching a tentative...
Reuters › Finance › 2 months ago
OxyContin maker Purdue Pharma LP filed for bankruptcy protection after reaching a partial deal to resolve more than 2,600 lawsuits alleging it helped fuel the U.S. opioid crisis.
Sign In

Sign in to follow sources and tags you love, and get personalized stories.

Continue with Google
OR